FundedIQ
Artificial Intelligence

FathomX

FathomX is a Digital Health AI spin-off company from the National University of Singapore and National University Health System and is the brainchild of Dr Mikael Hartman (Breast Cancer Surgeon at NUH) and Dr Feng Meng Ling (Assistant Professor at the Saw Swee Hock School of Public Health). Our flagship product, FxMammo, is an AI Assistant that significantly improves the screening procedure for mammograms by reducing the false positive rates by as much as 67% and enhancing the clinical workflow by reducing the time taken to assess a screen as well as the number of radiologists required per screen. Our algorithm was based off over 3 years of research at NUS and we have recently published on the prestigious AAAI Workshop and Jama Open Network Journal. We are also a portfolio company of the MedTech JUMPStart Program. FathomX’s unique AI Model for mammogram started out in a global competition - The Dream Challenge organised by the United States’ Whitehouse. As the top Asian team in the global competition that featured more than 100 participants from around the world, the founders decided to spin-off the company with the support of NUS Enterprise. From the time of the competition, the AI model has also progressed tremendously in its predictive accuracy, refinement and users’ preference are incorporated and continuously upgraded to meet differing and progressing needs. Within a year from incorporation, the company has secured several research collaborations with major hospitals including the National University Hospital and Kandang Kerbau Women and Children’s Hospital in Singapore, Tokyo Medical and Dental University in Japan and Taipei Medical University in Taiwan. On the commercialisation front, a co-investment and co-development deal with Hewlett Packard Enterprise (HPE) was signed that will see the company gain access to HPE’s engineering team as well as potential access to over 130 hospital clients in the APAC region. We have also executed a data transfer agreement with multiple research agencies like Lifepool (Peter MacCallum Cancer Centre in Australia). The company has also recently accepted SGD1.25 Million I2Start funding Pathway and is also one of the finalists of the prestigious MedTech Innovator competition in Singapore. FathomX has also been featured on multiple news media including Channel News Asia, Tamil Seithi, Channel 8 News, Enterprise SPARKS and TEDx. We have also come up as either the champion or finalist in several competitions like the Hubei Innovate Challenge, Qingdao Innovation Challenge, IET Innovation Award Shortlist and the SHE1K C-Shark Tank' Competition.

www.fathomx.co Singapore, Singapore 1-10 employees
Total raised
$1.6M
Rounds
2
Latest
Series Unknown
Jun 2023

FathomX is a Digital Health AI spin-off company from the National University of Singapore and National University Health System and is the brainchild of Dr Mikael Hartman (Breast Cancer Surgeon at NUH) and Dr Feng Meng Ling (Assistant Professor at the Saw Swee Hock School of Public Health). Our flagship product, FxMammo, is an AI Assistant that significantly improves the screening procedure for mammograms by reducing the false positive rates by as much as 67% and enhancing the clinical workflow by reducing the time taken to assess a screen as well as the number of radiologists required per screen. Our algorithm was based off over 3 years of research at NUS and we have recently published on the prestigious AAAI Workshop and Jama Open Network Journal. We are also a portfolio company of the MedTech JUMPStart Program. FathomX’s unique AI Model for mammogram started out in a global competition - The Dream Challenge organised by the United States’ Whitehouse. As the top Asian team in the global competition that featured more than 100 participants from around the world, the founders decided to spin-off the company with the support of NUS Enterprise. From the time of the competition, the AI model has also progressed tremendously in its predictive accuracy, refinement and users’ preference are incorporated and continuously upgraded to meet differing and progressing needs. Within a year from incorporation, the company has secured several research collaborations with major hospitals including the National University Hospital and Kandang Kerbau Women and Children’s Hospital in Singapore, Tokyo Medical and Dental University in Japan and Taipei Medical University in Taiwan. On the commercialisation front, a co-investment and co-development deal with Hewlett Packard Enterprise (HPE) was signed that will see the company gain access to HPE’s engineering team as well as potential access to over 130 hospital clients in the APAC region. We have also executed a data transfer agreement with multiple research agencies like Lifepool (Peter MacCallum Cancer Centre in Australia). The company has also recently accepted SGD1.25 Million I2Start funding Pathway and is also one of the finalists of the prestigious MedTech Innovator competition in Singapore. FathomX has also been featured on multiple news media including Channel News Asia, Tamil Seithi, Channel 8 News, Enterprise SPARKS and TEDx. We have also come up as either the champion or finalist in several competitions like the Hubei Innovate Challenge, Qingdao Innovation Challenge, IET Innovation Award Shortlist and the SHE1K C-Shark Tank' Competition.

FathomX has raised $1.6M across 2 rounds. Its most recent round was a Series Unknown in Jun 2023. Full funding history, investors, and team are detailed below.

Funding history

2 rounds · 1 visible Unlock with plan

2 rounds on record — latest round shown, the rest unlock with a paid plan.

Date
Round
Amount
Lead investor
Jun 6, 2023
Series Unknown
Undisclosed

Unlock 1 earlier round — dates, amounts, round types — plus the lead investor for every round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

FathomX is featured in

Similar companies

Greenfi

GreenFi is a SaaS based ESG Risk & Due Diligence Software. Our platform helps Financial Institutions and Corporates with ESG Due Diligence, Risk Assessments & Automated Decisioning for Sustainable Investments. Our ESG AI platform helps Banks to increase origination of sustainable financing, thus SMEs get increased access to capital for transitioning to sustainable operations. GreenFi is a technology platform for businesses to simplify access to green financing. Our mission is to become the platform that powers the world's transition to zero emissions. We work extensively across financial services, supply chain and debt markets. GreenFi is the ESG intelligence platform bringing clarity to the new climate economy. Built on the foundation of ESG data and AI, GreenFi provides data, tools, and frameworks to help investors, corporates, and governments build and finance the new climate economy. Explore GreenFi: https://greenfi.ai

Seed $2.0M
WIZ.AI

WIZ is a fast growing startup deploying cutting edge conversational voice AI technology into large corporations throughout Southeast Asia. Backed by globally leading venture capital funds, we are rapidly expanding our humanistic AI conversational solutions across industries. With offices in Singapore, Nanjing and Jakarta, our diverse team of scientists, researchers, linguists, dialogue designers have cross-functional expertise, and are constantly pushing the boundaries of humanistic AI conversation for ASEAN languages.

Series B
Augmentus

Augmentus offers a robotics platform that incorporates advanced 3D scanning and AI technology to make programming robots without coding possible within minutes. Our exclusive features allow for easy digitization of the work environment, automated creation of robot paths, and a user-friendly graphical interface that eliminates the need for coding and CAD files when instructing the robot. The renowned robotics and advanced manufacturing companies around the world are utilizing Augmentus' products for various tasks like robot sandblasting, shot peening, sanding, painting, spraying, and welding. By removing time, cost, and skill barriers in industrial automation, our solutions enable manufacturers to achieve faster return on investment. Users of Augmentus have reported up to a 70% reduction in costs and deployments more than 21 times faster. Augmentus brings about a new era of human-machine interaction, making robotic automation accessible to all.

Venture - Series Unknown
5.Y

5.Y is revolutionizing brand and product experiences through GLUCOSE Agentic AI, an advanced platform that enables businesses to connect with and support customers across multiple channels in real time. This innovative technology helps companies increase revenue, build customer loyalty, and take control of valuable data. With a strong presence in various industries, 5.Y is poised to shake up the CRM/CX market and tap into the lucrative Agentic AI sector.

Seed $400k
TopviewAI

TopviewAI is a rapidly growing platform for creating product content powered by artificial intelligence.

Series A $8.5M
GAIB

GAIB is a crypto-AI platform being developed as the financial cornerstone for the future of artificial intelligence and computers. It aims to tokenize GPUs in order to make AI computing more accessible, which is crucial for training and running AI models.

Series Unknown $10.0M
Zeya Health

Zeya is an AI co-pilot that automates admin and streamlines workflows for outpatient clinics across Asia.

Pre-Seed $500k
Idle

Idle is a sophisticated AI operating system tailored for businesses in the beauty and wellness industry. Its innovative multi-agent design streamlines multiple backend tasks, such as scheduling, customer relationship management, payments, staffing, marketing, and business expansion. Specifically designed for salons, barber shops, spas, and wellness centers, Idle enhances profitability, decreases administrative work, and facilitates intelligent decision-making with the help of predictive analytics.

Pre-Seed $10k
SleekFlow

SleekFlow is an AI platform that helps businesses turn conversations into sales. With clients in over 80 countries, we bring together various messaging channels like WhatsApp, Instagram, Messenger, and more in one organized workspace. Integrated with e-commerce tools and CRM systems, our AI Revenue Agent guides customers from initial inquiry to purchase, recommending products, processing payments, and scheduling appointments. Our Inbox Copilot streamlines communication, automates tasks, and identifies sales opportunities, enabling teams to close deals more efficiently. Based in multiple locations, we recently raised an additional $23.5 million in funding from investors such as Atinum Investment and Moses Tsang.

Series Unknown $5.0M
CloudSEK

CloudSEK provides AI-based tools to detect and handle online risks. They specialize in giving information on cyber threats, brand weaknesses, and areas that are vulnerable to attacks. By using advanced AI technology, CloudSEK assists businesses in anticipating security problems and taking preventive action. Their services involve thorough monitoring of online assets, allowing clients to make informed choices about their cybersecurity plans. With their unique platform, CloudSEK helps sales teams better understand market trends and safeguard their interests.

Series B $19.0M
Groundup.ai

Services offered by Groundup.ai include sound sensors, preventative maintenance based on conditions, internet of things connections, Industry 4.0 technology, predictive maintenance, artificial intelligence, machine learning, computer vision, and safety monitoring.

Series A $4.3M
CrediLinq.Ai

CrediLinq.Ai is upsetting SME loaning utilizing AI and AI. They Linq man-made reasoning and AI with credit guaranteeing.

Series A
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.